TGM2 and celiac disease: Based on Schuppan et al., the medical evaluation of celiac disease examines tissue transglutaminase antibodies (anti-tTG) and deamidated gliadin peptide antibodies (anti-DGP) as they help determine disease state and measure patient gluten consumption.